UK markets close in 4 hours 59 minutes

Olympus Corporation (OLYMY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
14.43+0.02 (+0.14%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.41
Open14.44
BidN/A x N/A
AskN/A x N/A
Day's range14.42 - 14.51
52-week range11.91 - 18.53
Volume88,273
Avg. volume50,569
Market cap16.93B
Beta (5Y monthly)0.57
PE ratio (TTM)68.71
EPS (TTM)0.21
Earnings dateN/A
Forward dividend & yield0.11 (0.79%)
Ex-dividend date30 Mar 2023
1y target estN/A
  • Business Wire

    Canon Medical Systems and Olympus Announce Business Alliance regarding Endoscopic Ultrasound Systems

    TOKYO, January 15, 2024--Canon Medical Systems Corporation (Canon Medical) and Olympus Corporation (Olympus), today announced that we have reached an agreement to collaborate on Endoscopic Ultrasound Systems. Canon Medical will develop and manufacture diagnostic ultrasound systems used in Endoscopic Ultrasonography1 (EUS), and Olympus will perform the sales and marketing efforts. The aim of this collaboration between Canon's Aplio i8002 diagnostic ultrasound system for EUS and Olympus' Ultrasoun

  • PR Newswire

    Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility

    As part of Lung Cancer Awareness Month, Olympus Corp. of the Americas (OCA) and the American Lung Association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.

  • PR Newswire

    Olympus Announces Two New Category I CPT Codes for the iTind Procedure

    Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today that the American Medical Association (AMA) will issue two new Category I Current Procedural Terminology (CPT®) codes for the iTind™ procedure, a minimally invasive treatment for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).